Form 4: Saba Capital Management Sells BlackRock Capital Allocation Term Trust Shares

Saba Capital Management, a 10% owner and director, sold 1,821 shares of BlackRock Capital Allocation Term Trust at $14.77 per share on March 18, 2025.

Summary

• On March 18, 2025, Saba Capital Management, L.P., through Zachary Gindes, and Boaz Weinstein, sold 1,821 shares of BlackRock Capital Allocation Term Trust (BCAT) common stock.
• The sale price was $14.77 per share.
• Following the transaction, Saba Capital Management, L.P. indirectly owns 11,809,531 shares of BCAT.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of share sales. The impact depends on the size of the sale relative to overall holdings and market perception of Saba's actions.

Negatives

• Saba Capital Management reduced its holdings in BlackRock Capital Allocation Term Trust.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a company (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital Management selling shares, potentially impacting the stock price.

Key Dates

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital Management, Share Sale, Form 4, Beneficial Ownership, Zachary Gindes, Boaz Weinstein